AstraZeneca - McKnight's Long Term Care News

AstraZeneca

Clinical briefs for Monday, Dec. 7

Researchers urge priority vaccination for individuals with diabetes … AstraZeneca vaccine approval iffy in U.S. with current data, OWS scientist says … WHO trial finds no benefit of 4 drugs for hospitalized COVID patients … COVID antiviral pill trials move forward, long-term care component added … Interactive tool helps find your place in line for…

Clinical briefs for Tuesday, Sept. 15

AstraZeneca COVID vaccine trial on hold in U.S. despite resuming elsewhere … Collapsed lung a complication of COVID-19; specialist care needed for older men … Pfizer, BioNTech enlarge late-stage coronavirus vaccine trial … Diet may protect former smokers against rheumatoid arthritis … AHCA/NCAL video celebrates recoveries from COVID-19 in long-term care

Clinical Briefs for Tuesday, June 2

First federal count: more than 25,000 coronavirus deaths in nursing homes … AstraZeneca’s heart drug for high-risk patients receives FDA approval … Senior living operator balances safety, quality of life in the COVID-19 era … U.S. hospitals slash hydroxychloroquine use after studies reveal risks, suggest ineffectiveness … CDC: U.S. COVID-19 transmission likely began in January

Seroquel generics okay, appeals court says

AstraZeneca is not entitled to more exclusivity with its antischizophrenic medication, an appeals court agreed last week. The company had claimed its drug, Seroquel, deserved another three-year extension under the Food Drug and Cosmetic Act.

Next post in Products